1 / 85

Venothrombotic Disease Diagnosis and Treatment

Venothrombotic Disease Diagnosis and Treatment. Jeffrey P Schaefer, MSc, MD, FRCPC January 31, 2006 slides available: www.ucalgary.ca/~jpschaef guidelines available: www.chest.org. Objectives. Venothrombotic Disease diagnosis therapy / prevention. Data Sources - Therapy.

liam
Download Presentation

Venothrombotic Disease Diagnosis and Treatment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Venothrombotic DiseaseDiagnosis and Treatment Jeffrey P Schaefer, MSc, MD, FRCPC January 31, 2006 slides available: www.ucalgary.ca/~jpschaef guidelines available: www.chest.org

  2. Objectives • Venothrombotic Disease • diagnosis • therapy / prevention

  3. Data Sources - Therapy American College of Chest Physicians CHEST Supplement September 2004 Volume 126(3) **Uptodate & eMedicine are not recent ***

  4. full text guidelines available to anyonewww.chest.org  supplements

  5. Venothrombotic disease (VTED) • superficial thrombophlebitis • deep vein thrombosis • lower limb • upper limb • pulmonary thromboembolism • post-thrombotic syndrome

  6. Superficial Vein Thrombophlebitis

  7. Superficial Leg Veins  Saphenous (L & S)

  8. Superficial Vein Thrombophlebitis

  9. Superficial Thrombophlebitis • Presentation • inflammation along course of vein • complicates 20% of IV infusions

  10. Superficial Thrombophlebitis • Conditions Similarly Presenting • DVT • cellulitis • lymphangitis • panniculitis • insect bite • erythema nodosum • cutaneous polyarteritis nodosa (PAN) • sarcoid granuloma • Kaposi's sarcoma

  11. Superficial Thrombophlebitis • Diagnosis • risk factor assessment • clinical assessment • inflammation along superficial vein • rule out DVT*** • rule out other conditions

  12. Superficial Thrombophlebitis and Deep Vein Thrombosis • 42 leg ST without clinical DVT  • found 4 above knee DVTs and 1 below knee DVT • DVT 12% J Vasc Surg 1990 Jun;11(6):818-23 • 21 ambulatory ST long saphenous vein  • found 7 high probability V/Q scans • PE = 33.3% (95%CI: 15 to 57) • clinical PE present in only one J Vasc Surg 1999 Dec;30(6):1113-5

  13. Potentially Lethal Misnomer  SFV = deep

  14. Superficial Thrombophlebitis Tx • Complication of Infusion • topical or oral NSAID • warmth / elevation • Spontaneous Superficial Thrombophlebitis • intermediate dosages of UFH or LMWH for at least 4 weeks • JPS  dalteparin 5,000 sq od x 4 wks for most, consider full dose tinzaparin if severe

  15. Take-Home-PointsSuperficial Thrombophlebitis (ST) • Exclude DVT among ST patients • Superficial Femoral Vein is a deep vein • Spontaneous ST  heparin • Infusion-related ST  NSAID

  16. Deep Vein Thrombosis

  17. Incidence of DVT and PE • 117 / 100,000 / year among all • 900 / 100,000 / year among 85 year olds Am Fam Phys 2004;69(12):2829-36 • Alberta 2005 Population (3.2 m) • 3,223,400 x 117 / 100,000 = 3,771 VTEDS/yr • 3,223,400 x $400 = $1,289,360,000

  18. Calgary Health RegionJan 1 to June 30, 2001 • 1,400 patients investigated for DVT • 33% inpatient • 40% emergency dept • 27% outpatient • 3,175 patients investigated for PE • 60% inpatient • 25% emergency dept • 15% outpatient QIHI

  19. Calgary Health RegionJan 1 to June 30, 2001 • DVT tests • 4,200 leg ultrasounds • 2,500 bilateral • 1,700 unilateral • 95 venograms • PE tests • 1,400 V/Q scans • 130 CT scans • 100 pulmonary angiograms • Estimated cost: $1,500,000QIHI

  20. DVT - diagnosis • Clinical Suspicion • D-dimer screen • Compression Ultrasound • Venography • (MRI expensive) • (IPG ‘discredited’)

  21. MRI  Positive for DVT • sensitivity 100% & specificity 96% J Vasc Surg 1993 Nov;18(5):734-41

  22. DVT - diagnosis • Clinical Suspicion - any one feature performs poorly

  23. Well’s DVT Clinical Prediction Rule • Cancer 1 • Paralysis 1 • Bedridden 1 • Tender vein 1 • Leg swollen 1 • Calf swollen 1 • Pitting edema 1 • Collaterals dilated 1 • Alternative dx - 2 • TOTAL: 3 (high 75%), 1-2 (mod 17%), 0 (low 3%) Lancet 1997;350:1795-8

  24. Well’s Criteria - study excluded those with previous VTED, needed indefinite anti-coagulation, imminent death

  25. D - dimer • D-dimer Assay • D-dimer is breakdown product of fibrinolysis • high sensitivity (98%) & modest specificity (~50%) • useful for excluding DVT and PE • not useful for confirming diagnosis • SHOULD NOT TO BE USED • post-operative patient • pregnant patient • patient with malignancy

  26. Duplex Ultrasonography • Duplex US • above knee DVT • Sens = 96% • Spec = 96% Haemostasis 23:61-7 • calf dvt • sens = 80%

  27. Venography • Gold standard (sens 100%, spec 100%)

  28. CHR Protocol

  29. Pulmonary Thromboembolism

  30. Pulmonary Thromboembolism • Diagnosis • Clinical • D-dimer • Ventilation - Perfusion Scan (V/Q scan) • Spiral CT Scan • Pulmonary Angiogram

  31. PE - clinical diagnosis • Symptoms of PE in 117 previously normal patients • dyspnea 73% • pleuritic pain 66 • cough 37 • leg swelling 28 • leg pain 26 • hemoptysis 13 • palpitations 10 • wheezing 9 • angina-like pain 4 Chest 100:598, 1991

  32. PE - clinical diagnosis • Signs of PE in 117 previously normal patients • tachypnea (20/min) 70% • rales (crackles) 51 • tachycardia (>100/min) 30 • fourth heart sound 24 • increased P2 23 • diaphoresis 11 • temperature >38.5°C 7 • wheezes 5 • Homans' sign 4 • right ventricular lift 4 • pleural friction rub 3 • third heart sound 3

  33. Well’s PE Clinical Prediction Rule • Signs/Symptoms of DVT 3.0 • measured leg swelling AND • pain with palpation in the deep vein region • Alternative diagnoses less likely than PE 3.0 • history, physical exam, chest X-ray, EKG, lab results • Pulse > 100 beats/min 1.5 • Immobilization 1.5 • bedrest (except access to BR)  3 days OR • surgery in previous 4 weeks • Previous DVT or PE 1.5 • Hemoptysis 1.0 • Malignancy 1.0 • receiving active treatment for cancer OR • have received treatment for cancer within the past 6 months OR • are receiving palliative care for cancer • TOTAL: >6 (high 78%), 2-6 (mod 28%), < 2 (low 3%) Thromb Haemost 2000;83;418

  34. D-Dimer • Same as PE

  35. PE - diagnosis (V/Q scan) • high probability V/Q scan (2 defects)

  36. V/Q scan normal  PE ruled out near normal  PE ruled out low probability  can’t rule in nor out indeterminate  can’t rule in nor out high probability  PE ruled in

  37. Most V/Q Scans are non-diagnostic

  38. PE - diagnosis (spiral CT scan)

  39. Sprial CT Scanning

  40. Helical (Spiral) CT Scan • 914 ER pts: chest pain and dyspnea • 858 eligible for study • clinical assessment (Well’s) AND D-dimer • +/- Helical CT • +/- Compression Ultrasound J Emerg Med 2005 Nov;29(4):399-404

  41. J Emerg Med 2005 Nov;29(4):399-404

  42. 409 with negative CT AND negative US 2 of these were diagnosed with DVT (day 37 & 73)

  43. PE - diagnosis Venography - gold standard - (100% / 100%)

  44. CHR Protocol

  45. Pregnancy • Ionizing Radiation Exposure • first 8 weeks has highest risk for in utero death • most frequent abnormality is microcephaly / mental retardation among term infants • 8 to 15 wk most sensitive period for retardation • risk of severe mental retardation • 4% for 10 rad • 60% for 150 rad • relative risk of childhood leukemia • RR = 1.5 – 2.0 (1 – 2 rad exposure) • 1:3000 (general population)  1:2000 • risk of sib of leukemic child 1:700

  46. Take-Home-PointsDiagnosis of DVT and PE • Multimodal approach • Clinical • D-dimer • US / VQ / Spiral CT • Studies exclude those with previous VTED • Fetal risk is low but anxiety may be high (having numbers is helpful)

  47. Overview of Prevention / Treatment Patient at Risk DVT PE Death Prevent DVT Treat DVT = Prevent PE Treat PE = Prevent More PE Treat PE

More Related